MedPath

The efficacy of adipose-derived stem cells as treatment of hypertrophic scar: a non-randomized controlled trial

Not Applicable
Recruiting
Conditions
Hypertrophic scar
Skin - Dermatological conditions
Registration Number
ACTRN12622000619741
Lead Sponsor
Theddeus O. H. Prasetyono
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
21
Inclusion Criteria

The subject has a hypertrophic scar which has persisted for at least 3 months after the initial wound healed
- The hypertrophic scar is of an area of at least 1 x 1 cm2
- The hypertrophic scar is at least 5-15 mm in thickness, confirmed with ultrasonography

Exclusion Criteria

- The scar is diagnosed as keloid
- The subject has systemic conditions such as diabetes mellitus, hypertension, etc
- The subject smoked or consumed alcohol within the last 6 months
- The hypertrophic scar received corticosteroid injection therapy within the last month
- Subjects have allergies to penicillin, streptomycin, and amphotericin

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath